Molecular targeted therapy for patients with melanoma: the promise of MAPK pathway inhibition and beyond

Author： Sullivan Ryan J Atkins Michael B

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.19, Iss.10, 2010-10, pp. : 1205-1216

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Targeted Therapy in Melanoma: A Way to Reverse Resistance to Conventional Drugs

Current Drug Delivery, Vol. 9, Iss. 1, 2012-01 ,pp. : 17-29

Bentham Science Publishers

Access to resources Recommend Favorite

Towards the Targeted Therapy of Melanoma

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 4, 2006-04 ,pp. : 387-393

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib

By Yau Thomas Pang Roberta Chan Pierre Poon Ronnie T

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 13, 2010-09 ,pp. : 2187-2198

Informa Healthcare

Access to resources Recommend Favorite

The future of targeted therapy approaches in melanoma

By Cantini Liliana P Meier Friedegund Sondak Vernon K Smalley Keiran SM

Expert Opinion on Drug Discovery, Vol. 4, Iss. 4, 2009-04 ,pp. : 445-456

Informa Healthcare

Access to resources Recommend Favorite

Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway

Current Cancer Drug Targets, Vol. 9, Iss. 2, 2009-03 ,pp. : 237-249

Bentham Science Publishers

Access to resources Recommend Favorite